We further assessed the association between BRD4 expression and tumor size from our 87 cases of EACs and found that BRD4 mRNA levels detected by qPCR were significantly associated with tumor size (Fig. S2A), poor tumor differentiation (Fig. S2B), and shorter survival (Fig. S2C). The gene discussed is BRD4; the disease is neoplasm.